Home owners will see housing assistance in the upcoming fiscal year with an income-based ResidentFirst pilot program the city ...

Mercury’s radiation-tolerant SSDRs are leveraged on all four tranches that L3Harris is developing for the PWSA Tracking Layer ...

Encouraging Phase 2 HIT data and recent FDA feedback support continued advancement of CAD-1005 as Cadrenal’s near-term development priority; broader 12-LOX platform remains a longer-term opportunity ...

Apply for wage top-up, professional development, release time and mandatory employer contribution funding for certified staff.

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

Evalauting breakout Illinois guard Keaton Wagler.

Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the ...

Deploys Capital into Cash-Flowing Manufacturing Businesses in Aerospace, Defense and IT Packaging -- Advances Dual Myostatin Assets Targeting Muscle Preservation in Potential Combination with GLP-1 ...

Received FDA clearance of Investigational New Drug application (IND) for PRT12396, mutant-selective JAK2V617F inhibitor in the first quarter of ...

NORCROSS, Ga., March 31, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...

Major League Baseball announced today it will revive its iconic This Week in Baseball franchise, with the debut of a new short-form “TWIB” episode every Friday at 12 p.m. ET on Major League Baseball’s ...

Fourth Quarter Highlighted by Clinical and Regulatory Milestones Positioning PF614 for Late-Stage Advancement ~ SAN DIEGO, CA / ACCESS Newswire / March 30, 2026 / Ensysce Biosciences, Inc.